share_log

康弘药业:监事会关于2023年股票增值权激励对象名单的公示情况说明及审核意见

Kanghong Pharmaceutical: Supervisory Committee\'s Public Explanation and Audit Opinions on the List of Incentives for Stock Value-Added Rights in 2023

SZSI ·  Dec 15, 2023 11:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more